← Back to patent-cliff list
Metenkefalin/Tridecactide
Tier C — Watch / tradeMetenkefalin/Tridecactide
Farmacija
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：DOR1
Brand：Enkorten
Indications (approved)：Multiple sclerosis
Regional status
US
-
EU
Approved
2010-02-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Metenkefalin/Tridecactide?
Approved indications include: Multiple sclerosis.
When does the Metenkefalin/Tridecactide patent expire?
No public expiry year is available for Metenkefalin/Tridecactide yet; this page updates once verified.
How do I get a quote for Metenkefalin/Tridecactide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29